Beryllium Discovery Overview
- Founded
-
2009

- Status
-
Acquired/Merged
- Employees
-
60

- Latest Deal Type
-
M&A
- Financing Rounds
-
3
- Investments
-
1
Beryllium Discovery General Information
Description
Provider of specialized drug discovery contract research services. The company's drug-discovery platform provides research services and engages in collaborations with leading pharmaceutical, innovative biotechnology and academic partners for protein engineering, expression and purification, as well as functional biology and protein structure designed to find unique therapeutic drugs helping pharmacy and biotech clients to address the scientific and business challenges facing drug discovery and to ultimately enable transformational health care outcomes.
Contact Information
Website
www.be4.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Formerly PE-Backed
Primary Office
- 3 Preston Court
- Bedford, MA 01730
- United States
+1 (781) 000-0000
Beryllium Discovery Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Beryllium Discovery Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Provider of specialized drug discovery contract research services. The company's drug-discovery platform provides resear
Drug Discovery
Bedford, MA
60
As of 2014
000.00
0.000
0000-00-00
000000&0
000.00
Beryllium Discovery Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Selcia | Corporate Backed or Acquired | Ongar, United Kingdom | 0 | 000000&0 | ||
0000000-00000 0000 | Corporation | New York, NY | 00000 | 00000 | 00000000000 | 00000 |
00000000 | Venture Capital-Backed | Lund, Sweden | 00 | 00000000000 | ||
0000000 | Formerly VC-backed | Strasbourg, France | 000 | 00.000 | 00000000000 | 00.000 |
000000 | Corporate Backed or Acquired | Martinsried, Germany | 00 | 000000&0 |
Beryllium Discovery Executive Team (5)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Chris Tauer | Chief Financial Officer | ||
Dalia Cohen Ph.D | Chief Scientific Officer & Head of Research |
Beryllium Discovery Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
0000 0000 00.0 | UCB (Biotechnology) | Board Member | 000 0000 |
00000 0000000-000000000 00.0 | Self | Board Member | 000 0000 |
Beryllium Discovery Signals
Beryllium Discovery Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Beryllium Discovery Investments (1)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
0000000 00000 | 13-Nov-2009 | 0000000000 | Discovery Tools (Healthcare) |
Beryllium Discovery Exits (1)
Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
---|---|---|---|---|---|
0000000 0000000000 | 13-Nov-2009 | 0000000000 | Completed |
|